Carmelo Carlo-Stella
Carmelo Carlo-Stella
Humanitas University and IRCCS Humanitas Research Hospital
Verified email at
Cited by
Cited by
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
M Di Nicola, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, ...
Blood, The Journal of the American Society of Hematology 99 (10), 3838-3843, 2002
Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy
S Siena, R Schiavo, P Pedrazzoli, C Carlo-Stella
Journal of Clinical Oncology 18 (6), 1360-1377, 2000
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen)
AM Gianni, M Magni, M Martelli, M Di Nicola, C Carlo-Stella, S Pilotti, ...
Blood 102 (2), 749-755, 2003
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells
J Reichel, A Chadburn, PG Rubinstein, L Giulino-Roth, W Tam, Y Liu, ...
Blood 125 (7), 1061-1072, 2015
Therapy of molecular relapse in acute promyelocytic leukemia
FL Coco, D Diverio, G Avvisati, MC Petti, G Meloni, EM Pogliani, A Biondi, ...
Blood, The Journal of the American Society of Hematology 94 (7), 2225-2229, 1999
Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after PD-1 Blockade in Relapsed/Refractory Lymphoma
RW Merryman, HT Kim, PL Zinzani, C Carlo-Stella, SM Ansell, ...
Blood 129, 1380-1388, 2017
Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome.
C Carlo-Stella, A Ganser, D Hoelzer
Journal of Clinical Investigation 80 (2), 286-293, 1987
Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells
A Ganser, C Carlo-Stella, J Greher, B Volkers, D Hoelzer
Cell therapy: achievements and perspectives
C Bordignon, C Carlo-Stella, MP Colombo, A De Vincentiis, L Lanata, ...
Haematologica 84 (12), 1110-1149, 1999
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
V Spina, A Bruscaggin, A Cuccaro, M Martini, M Di Trani, G Forestieri, ...
Blood 131, 2413-2425, 2018
Limited engraftment capacity of bone marrow–derived mesenchymal cells following T-cell–depleted hematopoietic stem cell transplantation
D Cilloni, C Carlo-Stella, F Falzetti, G Sammarelli, E Regazzi, S Colla, ...
Blood, The Journal of the American Society of Hematology 96 (10), 3637-3643, 2000
Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide
L Castagna, R Crocchiolo, S Furst, S Bramanti, J El Cheikh, B Sarina, ...
Biology of Blood and Marrow Transplantation 20 (5), 724-729, 2014
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death
R Zappasodi, SM Pupa, GC Ghedini, I Bongarzone, M Magni, AD Cabras, ...
Cancer research 70 (22), 9062-9072, 2010
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a …
M Di Nicola, R Zappasodi, C Carlo-Stella, R Mortarini, SM Pupa, M Magni, ...
Blood, The Journal of the American Society of Hematology 113 (1), 18-27, 2009
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.
Trabanelli S, Chevalier MF, Martinez-Usatorre A, Gomez-Cadena A, Salomé B ...
Nat Commun 8 (1), 593, 2017
Role of naive-derived T memory stem cells in T cell reconstitution following allogeneic transplantation
A Roberto, L Castagna, V Zanon, S Bramanti, R Crocchiolo, JE McLaren, ...
Blood 125, 2855-2864, 2015
CD34-positive cells: biology and clinical relevance
C Carlo-Stella, M Cazzola, P De Fabritiis, A De Vincentiis, AM Gianni, ...
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial.
PF Caimi, W Ai, JP Alderuccio, KM Ardeshna, M Hamadani, B Hess, ...
Lancet Oncol 22 (6), 790-800, 2021
Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxis
R Crocchiolo, S Bramanti, A Vai, B Sarina, R Mineri, E Casari, F Tordato, ...
Transplant Infectious Disease 17 (2), 242-249, 2015
Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors
C Carlo-Stella, A Tabilio, E Regazzi, D Garau, R La Tagliata, S Trasarti, ...
Bone Marrow Transplantation 20 (6), 465-471, 1997
The system can't perform the operation now. Try again later.
Articles 1–20